Health Trials

Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4)

1

Review clinical trials related to Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of 177Lu-PSMA-617 in People With Gliomas

The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type glioma.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Jun 4, 2026Locations: 7
Eligibility criteria

Diffuse astrocytoma, IDH-wildtype (grade 2-4) [+17]

Patient known to harbor any other non-canonical IDH mutations (i.e., non-R132H) [+16]

Read more